Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Chubb
US Department of Justice
Healthtrust
Julphar
Cantor Fitzgerald
Federal Trade Commission
Moodys
Merck

Generated: December 12, 2017

DrugPatentWatch Database Preview

Glenmark Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?

GLENMARK PHARMS has fifty-seven approved drugs.

There are eight tentative approvals on GLENMARK PHARMS drugs.

Summary for Glenmark Pharms

US Patents:0
Tradenames:48
Ingredients:49
NDAs:57
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms LtdBENDAMUSTINE HYDROCHLORIDEbendamustine hydrochloridePOWDER;IV (INFUSION)204771-001Mar 24, 2016APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark Pharms LtdVORICONAZOLEvoriconazoleTABLET;ORAL203503-002Sep 2, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark PharmsDESONIDEdesonideLOTION;TOPICAL209494-001Sep 26, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark Pharms IncRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL078542-002Nov 19, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark Pharms LtdACYCLOVIRacyclovirOINTMENT;TOPICAL205510-001Jul 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark Pharms LtdNAPROXEN SODIUMnaproxen sodiumTABLET;ORAL078314-002Apr 27, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark Pharms LtdPOTASSIUM CHLORIDEpotassium chlorideTABLET, EXTENDED RELEASE;ORAL203562-001Jul 26, 2016AB1RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark Pharms LtdATOMOXETINE HYDROCHLORIDEatomoxetine hydrochlorideCAPSULE;ORAL079019-003May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark PharmsCICLOPIROXciclopiroxCREAM;TOPICAL090273-001Nov 10, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark Pharms LtdVORICONAZOLEvoriconazoleTABLET;ORAL203503-001Sep 2, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Express Scripts
Johnson and Johnson
Chubb
Teva
Citi
US Department of Justice
McKinsey
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot